Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen recepto... ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.13 | 8.96551724138 | 1.45 | 1.58 | 1.42 | 129015 | 1.49534655 | CS |
| 4 | -0.0397 | -2.45107118602 | 1.6197 | 1.65 | 1.42 | 107712 | 1.53431103 | CS |
| 12 | -0.1702 | -9.72460290253 | 1.7502 | 1.83 | 1.42 | 160508 | 1.65624271 | CS |
| 26 | -4.71 | -74.8807631161 | 6.29 | 6.45 | 1.4 | 581197 | 1.59112002 | CS |
| 52 | -6.14 | -79.5336787565 | 7.72 | 8 | 1.4 | 315486 | 1.97500672 | CS |
| 156 | -6.26 | -79.8469387755 | 7.84 | 11.67 | 1.4 | 488293 | 3.86845942 | CS |
| 260 | -2.5 | -61.2745098039 | 4.08 | 36 | 1.4 | 392194 | 6.77839297 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
0
